|
Study: zaitoun, m.M., basha, m.A., elsayed, s.B., el deen, d.S., zaitoun, n.A., alturkistani, h., farag, a.A., abdelsalam, h., el-kenawy, h.A., mahmoud, n.E., alayouty, n.A., eladl, i.M., shahin, s., almarzooqi, m.-k., hendi, a.M., el-morsy, a., & elmokadem, a.H.(2021).Comparison of three embolic materials at partial splenic artery embolization for hypersplenism: clinical, laboratory, and radiological outcomes.Insights into imaging, 12(1).Https://doi.Org/10.1186/s13244-021-01030-5 was reviewed during internal quality system activities.The publication describes the microspheres used in partial splenic artery embolization (psae) procedures have been associated with pain, fever, vomiting, ascites, pleural effusion, splenic abscess, hematemesis, and portal vein thrombosis.Group two: patients experienced pain (49), fever (50), vomiting (22), ascites (7), pleural effusion (7), splenic abscess (1), hematemesis (1), portal vein thrombosis (1).Specific patient demographics were not included in this article.One patient developed a splenic abscess managed by pigtail catheter drainage and strong antibiotic coverage.Five patients had hematemesis controlled by conservative therapy.Portal vein thrombosis was detected in five patients on follow up ultrasound and ct within the first month after procedure (9-28 days).All thrombosis affected the main stem of portal vein.No specific treatment was given to these patients.Patients with ascites and/or pleural effusion caused abdominal discomfort and/or shortness of breath were managed by thoracocentesis and peritoneocentesis.
|